The Patent Finder

Asymmetric Ionizable Cationic Lipid for RNA Delivery

Arcturus Therapeutics, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 12 of these applications claim priority to application 14/546,105, filed Nov 18, 2014. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 9,365,610Asymmetric Ionizable Cationic Lipid for RNA Delivery
In force
 · Medium confidence
UsedRemaining
Arcturus Therapeutics, Inc.In forceMedium confidence
US 9,580,711Lipid Particles with Asymmetric Cationic Lipids for RNA Delivery
In force
 · Medium confidence
Arcturus Therapeutics, Inc.In forceMedium confidence
US 9,670,152Ionizable Cationic Lipid for RNA Delivery
In force
 · High confidence
Arcturus Therapeutics, Inc.In forceHigh confidence
US 9,850,202Ionizable Cationic Lipid for RNA Delivery
In force
 · High confidence
Arcturus Therapeutics, Inc.In forceHigh confidence
US 9,896,413Ionizable Cationic Lipid for RNA Delivery
In force
 · High confidence
Arcturus Therapeutics, Inc.In forceHigh confidence
US 9,951,002Ionizable Cationic Lipid for RNA Delivery
In force
 · High confidence
Arcturus Therapeutics, Inc.In forceHigh confidence
US 10,399,937Ionizable Cationic Lipid for RNA Delivery
In force
 · High confidence
Arcturus Therapeutics, Inc.In forceHigh confidence
US 10,556,861Ionizable Cationic Lipid for RNA Delivery
In force
 · High confidence
Arcturus Therapeutics, Inc.In forceHigh confidence
US 10,781,169Method of Synthesis of an Ionizable Cationic Lipid
In force
 · High confidence
Arcturus Therapeutics, Inc.In forceHigh confidence
US 9,567,296Ionizable Cationic Lipid for RNA Delivery
In force
 · High confidence
Arcturus Therapeutic, Inc.In forceHigh confidence
6 more records in this group · Pro
10 of 16 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 16, including 1 expired.
Upgrade to Pro
12 of these are in force and held by Arcturus Therapeutics, Inc..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited